Welcome on the DDIM-Website of Simone Lorenz-Asmus

 
User photo

Simone Lorenz-Asmus

Organisational development and interim management

Interim executive for organisational development and transformation in pharma, biotech and healthcare. My focus is Europe, the GCC and the USA.

from now
Interim Manager since: 03/2024
Update: 02.11.2026

Contact data

Lorenz Asmus Interim Management, Frankfurt

Zur Kalbacher Höhe 21a
D-60438 Frankfurt
rq.fhzfn-mareby@rabzvf

Telefon Mobile
+49 1721824463

Social networks

Personal data

Date of birth
06.03.1979 (Age:47)

Short profile

Intro
I am Simone Lorenz-Asmus, an interim executive for organisational development and transformation in pharma, biotech and healthcare. My company is based in Frankfurt am Main, and my focus is Europe, the GCC and USA. Since 2024 I have run Lorenz Asmus Interim Management (LA|IM). I help boards and executive teams turn vision and strategy into an organisation that works day to day, with clear structures, decision rights and processes. Increasingly, this includes introducing AI into regulated organisations so that accountability is clear and the organisation is inspection-ready. My work begins with listening and looking closely. That is how I spot problems before they become expensive. I see the work through from the first analysis to full implementation. I am a sparring partner to boards and a mentor to leaders and teams, and I see potential in every person.
Experience overview
I started out in nursing, where I saw early on how deeply structures reach into people's everyday lives. I brought that perspective into the pharmaceutical industry, where structures must stand up to the authorities. Over more than twenty years I have developed and reshaped global and local organisational units and led them through inspections with authorities such as the EMA, FDA, BfArM and SFDA. I have built teams in Europe, the GCC, Africa and the USA and developed people into leaders. What I build keeps evolving after I have gone. I developed a qualification programme for distributors in twenty countries across the MEA region. After the pilot, it became the template for Latin America, the CIS region and Asia Pacific, and was later rolled out in the USA and Europe. The governance and compliance platforms I designed for it are still in use worldwide and now include AI. I have also guided five post-merger integrations. I have trained in coaching for my work with leaders.
Tasks
  • Change Management
  • Building a Company / Business
  • Consulting
  • Process Optimization
  • Internationalization
  • Organisationsentwicklung und Transformation 
  • Post-Merger-Integration
  • Vakanzüberbrückung und Geschäftskontinuität
Functions
  • Research & Development
  • Organization
  • Operations
  • Pharmacovigilance
  • Governance, Risk & Compliance (GRC)
Role in the company
  • 2nd Level / Division Management / Department Management
  • Consultant, Advisor
  • Interimsleitung Pharmakovigilanz
  • Interimsleitung Transformation
  • Vakanzüberbrückung auf Führungsebene
Industry experience
  • Pharmaceutical Industry
  • Biotech
  • Healthcare
  • Gesundheitswesen
Type of company
  • Corporation / Group
  • Medium-sized Enterprise
Regions (Regions where you have proven experience)
  • Europe (EU)
  • Dubai
  • Saudi Arabia
  • Switzerland
  • USA
Languages
  • German (Mother tongue)
  • English (Business fluent)
Special skills
  • Organisationsentwicklung und Transformation in regulierten Organisationen
  • Interim Management auf Führungsebene bei Vakanzen und in Übergangsphasen
  • Change Management und Kulturwandel
  • Führung globaler und lokaler Teams in mehr als 70 Ländern
  • Post-Merger-Integration von Governance, regulatorischen Prozessen und Unternehmenskulturen
  • Aufbau globaler und lokaler Pharmakovigilanz-Systeme nach GVP
  • Vorbereitung auf Audits und Inspektionen von Behörden wie EMA, FDA, BfArM und SFDA
  • Erfahrung als EU-QPPV und Stufenplanbeauftragte
  • Organisationsentwicklung und Interim Management im Gesundheitswesen der Golfregion
  • Einführung von KI in regulierte Organisationen nach ISO/IEC 42001 und EU AI Act

IM projects (self employed)


Company description

Vaccine manufacturer

City / place
Kopenhagen, Dänemark

Initial situation at the client

An internationally operating biotech company faced a critical situation in its regulatory safety organisation.
• need for interim leadership
• vacant EU QPPV position
• upcoming regulatory inspection
• missing oversight
• unclear service provider performance
• pharmacovigilance organisation not inspection-ready
• fragmented processes, few SOPs or policies
• risk of non-compliance in some areas

Mission
The aim was to make the regulatory safety function operational, inspection-ready and well led.
  • Team stabilisation and interim leadership
  • EU QPPV role with personal accountability
  • Preparing the handover to the successor
  • Governance of the PV system and organisational design
  • Process analysis and improvement, writing SOPs and policies
  • Vendor and service provider oversight
  • Inspection preparation
Measures taken
I took on the function from the first week and brought it step by step into a safe, audit-ready state.
  • Stabilisation, coaching, mentoring and professional leadership of the team
  • Registration as EU QPPV
  • Revision and rebuilding of SOPs and core processes
  • Gap analysis, improvement plan and implementation
  • Establishment of vendor oversight and service-level control
  • Preparation and support of the inspection as EU QPPV
  • Risk management
Achieved Achievements
By the end of the mandate, the function was stable, inspection-ready and fully handed over.
  • Regulatory operability in the market maintained
  • Team stabilised and given a new direction
  • Regulatory accountability without interruption
  • New oversight and governance structure implemented
  • Documented standards and processes in line with compliance requirements
  • Two audits passed successfully
  • Team stabilisation especially recognised by the client
Special challenges
When I arrived, the function had lived through more than five years of constant change, with changing leaders and no lasting stability in the team. It ran on improvisation rather than reliable structure. People were unsettled and the future was unclear.
  • I gave people direction, built trust and showed them that someone was there to take responsibility.
  • What had been ongoing chaos became a calm, stable function the team could rely on.

Work history (permanent employment)


One of the world’s leading manufacturers of life-saving medicines derived from human plasma and related therapies, active in more than 30 countries, with Marburg as its largest site.

City / place
Marburg
Remarks
PV responsibility for EEA, UK and Eastern and Central Intercontinental (ECI), more than 70 countries.
Team of 22, 6 in direct line and 16 safety officers in the matrix. Teams in Dubai and Saudi Arabia.
Post-merger integration of Vifor Pharma and Seqirus into the regional operating model.
Qualification programme for distributors in 20 MEA countries, later a template worldwide.
Introduced digital governance and compliance platforms.
Inspections and audits with EMA, MHRA, BfArM, SFDA and MOHAP.

Biopharmaceutical company headquartered in Dublin with subsidiaries in Germany, Switzerland and the USA, focused on orphan diseases, primary care and rheumatology.

City / place
Mannheim
Remarks
Built the global PV operations unit and led the PV post-merger integrations, three acquisitions in 18 months.
• Led integration teams, interface between acquirer and target
• Created and executed pre- and post-merger integration plans
• Change management
• Integration of PV systems and safety databases
• Global team with staff in the USA and Germany
• Standard processes under GVP, SOPs, oversight of PV service providers
• Represented PV in audits and inspections

Global group headquartered in Darmstadt, the world's oldest pharmaceutical and chemical company, with Healthcare, Life Science and Performance Materials businesses.

City / place
Darmstadt
Remarks
Supported the drug safety teams in affiliates and regional hubs, with a focus on global process standardisation and PV governance for Europe, MEA, APAC and the USA.
• Developed and implemented SOPs
• Defined requirements for a drug safety database solution together with IT
• Processed safety information from systematic data collections
• Global Process Owner GVP
• Improved PV compliance in preparation for inspections

International healthcare company with its own research and development, focused on aesthetic dermatology and specialty neurology, with more than 2,400 employees in the group.

City / place
Frankfurt
Remarks
Senior Drug Safety Associate, from 2012 Senior Pharmacovigilance Manager, from 2014 Senior Manager Business Processes.
• Process analysis, improvement and definition in the PV system, SOPs, work instructions and training
• Built the medical device vigilance system and developed the global medical device vigilance strategy
• Monitored global compliance and rolled the strategy out to affiliates and third parties
• Built a training system

Education

Notes / specifics
Vier Module: Organisationsstrukturen verstehen, neu denken und verändern; Kernprozesse der Organisationsentwicklung; Managing & Leading Change; Transformation in der Praxis, Kultur, Macht und nachhaltige Veränderung. Abschluss voraussichtlich Februar 2027.
Notes / specifics
Wahlmodul Pharmazeutische Industrie, Masterarbeit zu Outsourcing in der pharmazeutischen Industrie. Zusatzmodul Ambient Assisted Living.
Notes / specifics
Abschluss als Diplom-Betriebswirtin (FH). Diplomarbeit zur Versorgung von Menschen mit Demenz an der Schnittstelle von Kranken- und Pflegeversicherung.
Notes / specifics
Staatliche Erlaubnis zur Führung der Berufsbezeichnung Krankenschwester, Regierungspräsidium Darmstadt, 2001.

Loading, please be patient...